» Articles » PMID: 33957119

50 Years of Structural Immunology

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2021 May 6
PMID 33957119
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Fifty years ago, the first landmark structures of antibodies heralded the dawn of structural immunology. Momentum then started to build toward understanding how antibodies could recognize the vast universe of potential antigens and how antibody-combining sites could be tailored to engage antigens with high specificity and affinity through recombination of germline genes (V, D, J) and somatic mutation. Equivalent groundbreaking structures in the cellular immune system appeared some 15 to 20 years later and illustrated how processed protein antigens in the form of peptides are presented by MHC molecules to T cell receptors. Structures of antigen receptors in the innate immune system then explained their inherent specificity for particular microbial antigens including lipids, carbohydrates, nucleic acids, small molecules, and specific proteins. These two sides of the immune system act immediately (innate) to particular microbial antigens or evolve (adaptive) to attain high specificity and affinity to a much wider range of antigens. We also include examples of other key receptors in the immune system (cytokine receptors) that regulate immunity and inflammation. Furthermore, these antigen receptors use a limited set of protein folds to accomplish their various immunological roles. The other main players are the antigens themselves. We focus on surface glycoproteins in enveloped viruses including SARS-CoV-2 that enable entry and egress into host cells and are targets for the antibody response. This review covers what we have learned over the past half century about the structural basis of the immune response to microbial pathogens and how that information can be utilized to design vaccines and therapeutics.

Citing Articles

In silico λ-dynamics predicts protein binding specificities to modified RNAs.

Angelo M, Zhang W, Vilseck J, Aoki S Nucleic Acids Res. 2025; 53(5).

PMID: 40066880 PMC: 11894534. DOI: 10.1093/nar/gkaf166.


Structural mapping of polyclonal IgG responses to HA after influenza virus vaccination or infection.

Leon A, Rodriguez A, Richey S, Torrents de la Pena A, Wolters R, Jackson A mBio. 2025; 16(3):e0203024.

PMID: 39912630 PMC: 11898601. DOI: 10.1128/mbio.02030-24.


Adaptive multi-epitope targeting and avidity-enhanced nanobody platform for ultrapotent, durable antiviral therapy.

Xiang Y, Xu J, McGovern B, Ranzenigo A, Huang W, Sang Z Cell. 2024; 187(24):6966-6980.e23.

PMID: 39447570 PMC: 11748749. DOI: 10.1016/j.cell.2024.09.043.


Structural Mapping of Polyclonal IgG Responses to HA After Influenza Virus Vaccination or Infection.

Leon A, Rodriguez A, Richey S, Torrents de la Pena A, Wolters R, Jackson A bioRxiv. 2024; .

PMID: 39026813 PMC: 11257458. DOI: 10.1101/2024.07.08.601940.


Use of phase plate cryo-EM reveals conformation diversity of therapeutic IgG with 50 kDa Fab fragment resolved below 6 Å.

Lin H, Wang C, Huang S, Lin S, Kato T, Namba K Sci Rep. 2024; 14(1):14079.

PMID: 38890341 PMC: 11189423. DOI: 10.1038/s41598-024-62045-8.


References
1.
Gunn R, Herrin B, Acharya S, Cooper M, Wilson I . VLR Recognition of TLR5 Expands the Molecular Characterization of Protein Antigen Binding by Non-Ig-based Antibodies. J Mol Biol. 2018; 430(9):1350-1367. PMC: 5915902. DOI: 10.1016/j.jmb.2018.03.016. View

2.
Ke Z, Oton J, Qu K, Cortese M, Zila V, McKeane L . Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature. 2020; 588(7838):498-502. PMC: 7116492. DOI: 10.1038/s41586-020-2665-2. View

3.
Altman M, Bennink J, Yewdell J, Herrin B . Lamprey VLRB response to influenza virus supports universal rules of immunogenicity and antigenicity. Elife. 2015; 4. PMC: 4552221. DOI: 10.7554/eLife.07467. View

4.
Zanotti K, Silva G, Creeger Y, Robertson K, Waggoner A, Berget P . Blue fluorescent dye-protein complexes based on fluorogenic cyanine dyes and single chain antibody fragments. Org Biomol Chem. 2010; 9(4):1012-20. PMC: 3163152. DOI: 10.1039/c0ob00444h. View

5.
Wrapp D, Wang N, Corbett K, Goldsmith J, Hsieh C, Abiona O . Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020; 367(6483):1260-1263. PMC: 7164637. DOI: 10.1126/science.abb2507. View